tiprankstipranks
invoX doesn’t expect CFIUS to clear F-star deal, Dealreporter says
The Fly

invoX doesn’t expect CFIUS to clear F-star deal, Dealreporter says

Sino Biopharmaceutical’s invoX Pharma subsidiary does not anticipate a favorable outcome from the Committee on Foreign Investment of the United States, or CFIUS, review of its proposed deal to buy F-Star Therapeutics by the deadline of January 31, said Dealreporter, citing two sources, contacts tell The Fly.

Published first on TheFly

See Insiders’ Hot Stocks on TipRanks >>

Read More on FSTX:

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100
Bitcoin

Popular Articles